<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE341nnn/GSE341199/</Other></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE341199</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Hepatocyte RIPK1 scaffolding function protects against alcohol-induced liver injury by restraining ER stress-driven apoptosis and inflammation</name><description>Alcoholic liver disease (ALD) is a global health burden with limited therapeutic options. The pathogenesis of ALD involves hepatocyte death and inflammation, but the key regulatory mechanisms remain incompletely defined. Receptor-interacting protein kinase 1 (RIPK1) is a critical signaling molecule with distinct kinase-dependent and kinase-independent, scaffold-dependent functions. While RIPK1 kinase activity has been implicated in various pathologies, the role of its scaffolding function in the liver, particularly in ALD, is unknown. Here, using hepatocyte-specific RIPK1 knockout (Ripk1-hepKO) mice, we demonstrate that loss of RIPK1 markedly aggravates ethanol-induced liver injury. In both chronic and acute-binge ethanol feeding models, Ripk1-hepKO mice exhibited significantly elevated serum transaminases, enhanced hepatocyte apoptosis, and amplified hepatic inflammation with increased macrophage infiltration, without a change in steatosis. Transcriptomic analysis revealed enrichment of inflammatory pathways in Ripk1-hepKO livers. Mechanistically, we identified endoplasmic reticulum (ER) stress as a critical contributor to this phenotype. RIPK1 deficiency was associated with attenuated NF-κB/p65 signaling, preferential amplification of eIF2α-ATF4-CHOP-associated stress responses, and enhanced CHOP accumulation, while pharmacological modulation of ER stress-associated pathways using 4-phenylbutyrate (4-PBA) or ISRIB ameliorated hepatocyte apoptosis, liver injury, and inflammation in ethanol-fed Ripk1-hepKO mice. Translating these findings to human disease, liver specimens from ALD patients showed elevated hepatocyte apoptosis, CD68+ macrophage infiltration, and induction of ER stress markers. Our study unveils a previously unrecognized protective role for the scaffold function of hepatocyte RIPK1 in ALD, positioning RIPK1 scaffolding and ER stress-associated signaling as promising therapeutic targets for ALD.</description><dates><publication>2026/07/28</publication></dates><accession>GSE341199</accession><cross_references><GSM>GSM9901874</GSM><GSM>GSM9901873</GSM><GSM>GSM9901872</GSM><GSM>GSM9901871</GSM><GSM>GSM9901878</GSM><GSM>GSM9901877</GSM><GSM>GSM9901876</GSM><GSM>GSM9901875</GSM><GPL>24247</GPL><GSE>341199</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>